Unknown

Dataset Information

0

Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2.

ABSTRACT: Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly associated with late-onset autosomal dominant Parkinson's disease. We employed a new, parallel, compound-centric approach to identify a potent and selective LRRK2 inhibitor, LRRK2-IN-1, and demonstrated that inhibition of LRRK2 induces dephosphorylation of Ser910 and Ser935 and accumulation of LRRK2 within aggregate structures. LRRK2-IN-1 will serve as a versatile tool to pharmacologically interrogate LRRK2 biology and study its role in Parkinson's disease.

SUBMITTER: Deng X 

PROVIDER: S-EPMC3287420 | biostudies-literature | 2011 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly associated with late-onset autosomal dominant Parkinson's disease. We employed a new, parallel, compound-centric approach to identify a potent and selective LRRK2 inhibitor, LRRK2-IN-1, and demonstrated that inhibition of LRRK2 induces dephosphorylation of Ser910 and Ser935 and accumulation of LRRK2 within aggregate structures. LRRK2-IN-1 will serve as a versatile tool to pharmacologically interrogate LRRK2 biology and study its role  ...[more]

Similar Datasets

Unknown Differential Inhibition of LRRK2 in Parkinson's Disease Patient Blood by a G2019S Selective LRRK2 Inhibitor.
| S-EPMC8248170 | biostudies-literature
Unknown Rab29 activation of the Parkinson's disease-associated LRRK2 kinase.
| S-EPMC5753036 | biostudies-other
Unknown LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity.
| S-EPMC1904520 | biostudies-literature
Unknown Characterization of TAE684 as a potent LRRK2 kinase inhibitor.
| S-EPMC3433743 | biostudies-literature
Transcriptomics Idiopathic and LRRK2-associated Parkinson's disease
2015-12-01 | GSE51923 | GEO
Unknown Fibroblast Biomarkers of Sporadic Parkinson's Disease and LRRK2 Kinase Inhibition.
| S-EPMC5012155 | biostudies-literature
Unknown Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson's disease.
| S-EPMC7557909 | biostudies-literature
Unknown The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites.
| S-EPMC2759846 | biostudies-literature
Unknown The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease.
| S-EPMC4662256 | biostudies-literature
Unknown LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson's disease.
| S-EPMC5886254 | biostudies-other